Moyer, J.H.: Optimum therapy for essential hypertension. American Family Physician5: 103-114, 1972
2.
Brown, W.J., Brown, F.K., Krishan, I.: Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation43: 508-519, 1971.
3.
Wood, J.E.The Veins. Boston, Little, Brown and Co., 1965, pp 3-70, 175-189.
4.
Federer, W.T.: Experimental Design. New York, MacMillan, 1955, pp 483-522.
5.
Shepherd, J.T. : Role of the veins in the circulation. Circulation33: 484-491, 1966.
de Champlain, J., Krakoff, L., Axelrod, J.: Interrelationships of sodium intake, hypertension, and norephinephrine storage in the rat. Circulation Research Sup I to Vol. 24 & 25: 75-92, 1969.
8.
Dupont, J. and J. Sassard. : Vascular reactivity in spontaneously hypertensive, normotensive and hypotensive rats. BritishJournal of Pharmacology, 50: 185-188, 1974.
9.
Bloomfield, D.K., Cangiano, J.L.: Guanadrel and guanethidine in hypertension . Clinical Pharmacology and Therapeutics. 11: 200-204, 1970.
10.
Dustan, H.P. , Bravo, E.L., Tarazi, R.C.: Volume-dependent essential and steroid hypertension. American Journal of Cardiology31: 606-615, 1973.
11.
Ogilvie, R.I. , Schlieper, E.: The effect of hydrochlorothiazide on venous reactivity in hypertensive man. Clinical Pharmacology and Therapeutics11: 589-594, 1970.
12.
McLeod, P.V. , Ogilvie, R.I., Ruedy, J.: Effect of large and small doses of hydrochlorothiazide in hypertensive patients. Clinical Pharmacology and Therapeutics11: 733-739, 1970.
